Evidence map›Paper›PMID 36770901›Full record

ArticleMolecules (Basel, Switzerland)2023

Antibacterial Activity of Peptide Derivatives of Phosphinothricin against Multidrug-Resistant

Marija V Demiankova, Fabio Giovannercole, Maxim A Khomutov, Arthur I Salikhov, Laura Onillon, Vladimir T Valuev-Elliston, Byazilya F Vasilieva, Elena N Khurs, Nina I Gabrielyan, Sergey N Kochetkov and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Frontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Marija V DemiankovaGause Institute of New Antibiotics, Bol'shaya Pirogovskaya 11, 119021 Moscow, Russia.
Fabio GiovannercoleDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, I-04100 Latina, Italy.ORCID 0000-0003-0324-1398
Maxim A KhomutovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Arthur I SalikhovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Laura OnillonDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, I-04100 Latina, Italy.
Vladimir T Valuev-EllistonEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Byazilya F VasilievaGause Institute of New Antibiotics, Bol'shaya Pirogovskaya 11, 119021 Moscow, Russia.
Elena N KhursEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Nina I GabrielyanAcademician V.I. Shumakov Federal Research Centre of Transplantology and Artificial Organs, 123182 Moscow, Russia.
Sergey N KochetkovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Olga V EfremenkovaGause Institute of New Antibiotics, Bol'shaya Pirogovskaya 11, 119021 Moscow, Russia.ORCID 0000-0003-3131-1031
Daniela De BiaseDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, I-04100 Latina, Italy.ORCID 0000-0003-3536-9927
Alex R KhomutovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, 119991 Moscow, Russia.
Engelhardt Institute of Molecular Biology · RUGause Institute of New Antibiotics Russian Academy of Medical Sciences · RUSapienza University of Rome · ITV.I.Shumakov Federal Research Center of Transplantology and Artificial Organs · RU

Funding

Russian Science Foundation 22-14-00291Sapienza University of Rome RM11916B861B9985Sapienza University of Rome RM120172B6587496
6 · The paper itself

Abstract

The fast spread of bacteria that are resistant to many classes of antibiotics (multidrug resistant) is a global threat to human and animal health with a worrisome scenario ahead. Novel therapeutical strategies are of crucial importance to combat this phenomenon. For this purpose, we investigated the antimicrobial properties of the naturally occurring tripeptide Bialaphos and a dipeptide

Indexed as

Anti-Infective AgentsKlebsiella InfectionsAminobutyratesAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPeptidesAminobutyratesAnti-Bacterial AgentsAnti-Infective AgentsPeptidesphosphinothricinBialaphosEscherichia coliglutamine synthetaseKlebsiella pneumoniaemultidrug-resistant bacteriaphosphinothricin

Identifiers

PMID36770901
PMCPMC9920448
OpenAlexW4318460224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.